ACUTA CAPITAL PARTNERS, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,300,171
-65.7%
244,484
-17.8%
6.23%
-66.1%
Q2 2023$27,110,996
+41.5%
297,596
+2.4%
18.37%
+30.1%
Q1 2023$19,161,380
+70.4%
290,500
+33.6%
14.12%
+104.0%
Q4 2022$11,246,925
-70.3%
217,500
-60.7%
6.92%
-57.5%
Q3 2022$37,838,000
+51.0%
554,0000.0%16.29%
+16.7%
Q2 2022$25,052,000
-11.0%
554,0000.0%13.96%
+6.1%
Q1 2022$28,149,000
+11.3%
554,000
+3.6%
13.15%
+23.7%
Q4 2021$25,295,000
+916.7%
535,000
+608.6%
10.63%
+1110.9%
Q3 2021$2,488,000
-75.5%
75,500
-53.0%
0.88%
-78.3%
Q2 2021$10,144,000
+108.9%
160,500
+41.8%
4.05%
+131.5%
Q1 2021$4,856,000
-49.2%
113,161
-32.3%
1.75%
-32.7%
Q4 2020$9,555,000
+89.6%
167,0540.0%2.60%
+89.9%
Q3 2020$5,040,000
-18.8%
167,054
-12.1%
1.37%
-23.6%
Q2 2020$6,205,000
+10.5%
190,000
-9.3%
1.79%
-34.1%
Q1 2020$5,613,000
-2.2%
209,500
+11.7%
2.72%
+91.4%
Q4 2019$5,741,000
+55.3%
187,500
+11.6%
1.42%
+116.1%
Q2 2018$3,696,000168,0000.66%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders